Because chronic inflammatory diseases such as MS and RA in which T cell contact is likely to play a pathogenic part are mediated by Th1 and Th17, the production of CCL2 by monocytes/macrophages might be considered as an attempt to revert T cell polarization to a less inflammatory phenotype [39]. The gene discussed is CCL2; the disease is myeloid sarcoma.